The target countries of the pharmacological synthesis associated with leviticimendan and the inhibitors of angiopoietin II or ECA

摘要

It refers to a pharmacological component, including the first active component or pharmaceutically acceptable salt of levosimendan and the second active component as the second active component Among others, invertase inhibitors include ramipril, capopril, enlapril, Quinapril, etc. This combination has a synergistic effect on reducing stroke related hypertension complications and deaths